Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 24.
doi: 10.1002/1873-3468.70097. Online ahead of print.

Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation

Bing Yao  1   2 , Qiangbing Yang  3 , Christian J B Snijders Blok  1 , Mark A Daniels  1 , Pieter A Doevendans  4   5 , Raymond Schiffelers  3 , Joost P G Sluijter  1   2 , Zhiyong Lei  1   3
Affiliations

Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation

Bing Yao et al. FEBS Lett. .

Abstract

Prime editing (PE) represents a transformative genome-editing technology and enables precise insertions, deletions, and base substitutions without introducing double-strand breaks, thereby reducing undesired indels and off-target effects. Despite advancements in enhanced prime editors and optimized prime editing guide RNAs (pegRNAs), designing effective pegRNAs remains a major challenge. The phospholamban (PLN) R14del mutation is associated with cardiomyopathies, making it a crucial target for precise gene-editing strategies. In this study, we explored pegRNA features that contribute to high editing efficiency using the FluoPEER.PLN R14del reporter cell line. Through systematic screening, we identified three pegRNAs with significantly enhanced editing efficiency. Our findings underscore the importance of pegRNA secondary structure and stability in optimizing prime editing, providing valuable insights into precise gene correction strategies.

Keywords: PLN R14del mutation; Phospholamban; gene therapy; pegRNA optimization; prime editing.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Jang HK, Song B, Hwang GH and Bae S (2020) Current trends in gene recovery mediated by the CRISPR‐Cas system. Exp Mol Med 52, 1016–1027.
    1. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA and Zhang F (2013) Genome engineering using the CRISPR‐Cas9 system. Nat Protoc 8, 2281–2308.
    1. Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI and Liu DR (2017) Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage. Nature 551, 464.
    1. Komor AC, Kim YB, Packer MS, Zuris JA and Liu DR (2016) Programmable editing of a target base in genomic DNA without double‐stranded DNA cleavage. Nature 533, 420–444.
    1. Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A et al. (2019) Search‐and‐replace genome editing without double‐strand breaks or donor DNA. Nature 576, 149–157.

LinkOut - more resources